Danish Medicines Agency approves new drug for reimbursement
This article was originally published in Scrip
Executive Summary
The Danish Medicines Agency has approved Biocodex's Diacomit (stiripentol), an anticonvulsant, for general reimbursement. The Danish Medicines Agency has approved three medicinal products for reimbursement and declined to approve two in 2009 so far.